The Latest Cardiac and Vascular News
Funding round led by Prime Movers Lab ALLSTON, Mass., Sept. 16, 2021 /PRNewswire/ — Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential to treat and prevent multiple age-related diseases, today announced that it raised $40 million in an oversubscribed Series A round led by Prime Movers Lab. The […]
WEST CHESTER, Pa., Sept. 16, 2021 /PRNewswire/ — VESTECK, Inc., an early-stage medical device company, is pleased to announce the additional close of funds totaling >$5.2M of Series A financing, which includes conversion of all existing convertible notes. Philadelphia area investors BioAdvance (https://www.bioadvance.com/) and Angel Network (https://angelstarventures.com/) Kennett Square, PA lead these additional investments, joined by several other […]
Company on Schedule to Commence Trial Late This Year VANCOUVER and MINNEAPOLIS, Sept. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has received FDA approval for the Investigational Device Exemption (“IDE”) regarding the COSIRA-II IDE Clinical Trial. Following multiple discussions with FDA […]
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces that it has received final approval from the Patient Protection […]
PRAIRIE VILLAGE, Kan., Sept. 16, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Joe McConnell as Vice President of Business Operations and Finance and Irina Galkina as Controller. After graduating summa cum laude from Princeton University, McConnell joined the […]
6 Aeson® artificial hearts marketed to date Enrollment of the first cohort of 3 patients in the EFS1 in the USA finalized Cash position of €58 million at June 30, 2021, covering the Company’s activities through to mid-2022 Videoconference with Stéphane Piat today at 5 pm Paris time PARIS–(BUSINESS WIRE)–Regulatory News: […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the appointment of William D. Humphries to its board of directors. Additionally, Justin Klein, M.D., J.D., is stepping down from his role as […]
For the treatment, in the operating room, of atrial fibrillation, the most complex and most common arrhythmia in the world 11 French research centers have already joined the study in 2021 The first results will be published in Q3 2023 MARSEILLE, France – ( BUSINESS WIRE ) – Volta Medical, an innovative […]
SUZHOU, China, Sept. 14, 2021 /PRNewswire/ — Peijia Medical today announced the initiation of its multi-center clinical trial for TaurusNXT®, the third-generation transcatheter aortic valve (“TAVR”) system, following the first successful patient implant in Zhongshan Hospital of Fudan University. Led by Professor Ge Junbo, the procedure was completed successfully with support from the […]
Company Expects New Personal Medical Device Kit to be available to customer by early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 14, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has developed a personal medical device kit, Biokit, a bundled home-use set […]
